Antigua and Barbuda vs New Zealand: Polio vaccine: inactivated second or third-dose polio vaccine (IPVc)
Antigua and Barbuda
88.0%
in 2025
New Zealand
88.0%
in 2025
Antigua and Barbuda rank
89th
New Zealand rank
89th
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) over time
- Antigua and Barbuda
- New Zealand
How they compare
Antigua and Barbuda currently reports 88.0% against 88.0% in New Zealand, a difference of 0.0%.
The two have swapped places 1 time across 5 shared years of data; in 2021 it was Antigua and Barbuda ahead.
Antigua and Barbuda ranks 89th and New Zealand ranks 89th of 194 countries.
Antigua and Barbuda has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher polio vaccine: inactivated second or third-dose polio vaccine (ipvc), Antigua and Barbuda or New Zealand?
- Antigua and Barbuda, at 88.0% against 88.0% in New Zealand as of 2025.
- What is the difference in polio vaccine: inactivated second or third-dose polio vaccine (ipvc) between Antigua and Barbuda and New Zealand?
- 0.0%, with Antigua and Barbuda ahead.
- How many years of comparable data are there for Antigua and Barbuda and New Zealand?
- 5 years are reported by both, from 2021 to 2025.
- How do Antigua and Barbuda and New Zealand rank globally for polio vaccine: inactivated second or third-dose polio vaccine (ipvc)?
- Antigua and Barbuda ranks 89th and New Zealand ranks 89th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.